Mind Medicine Inc (NASDAQ:MNMD)’s traded shares stood at 0.41 million during the last session, with the company’s beta value hitting 1.61. At the close of trading, the stock’s price was $5.57, to imply an increase of 1.92% or $0.1 in intraday trading. The MNMD share’s 52-week high remains $12.22, putting it -119.39% down since that peak but still an impressive 56.73% since price per share fell to its 52-week low of $2.41. The company has a valuation of $156.85M, with an average of 0.74 million shares in intraday trading volume over the past 10 days and average of 904.66K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Mind Medicine Inc (MNMD), translating to a mean rating of 1.10. Of 2 analyst(s) looking at the stock, 0 analyst(s) give MNMD a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.28.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mind Medicine Inc (NASDAQ:MNMD) trade information
After registering a 1.92% upside in the last session, Mind Medicine Inc (MNMD) has traded red over the past five days. The 5-day price performance for the stock is -4.79%, and -9.21% over 30 days. With these gigs, the year-to-date price performance is 52.19%. Short interest in Mind Medicine Inc (NASDAQ:MNMD) saw shorts transact 9.45 million shares and set a 10.45 days time to cover.
The extremes give us $14 and $22 for target low and target high price respectively. As such, MNMD has been trading -294.97% off suggested target high and -151.35% from its likely low.
Mind Medicine Inc (MNMD) estimates and forecasts
Looking at statistics comparing Mind Medicine Inc share performance against respective industry, we note that the company has outperformed competitors. Mind Medicine Inc (MNMD) shares are -49.36% down over the last 6 months, with its year-to-date growth rate higher than industry average at 34.84% against 17.60%. Revenue is forecast to grow 37.80% this quarter before jumping 47.50% for the next one.
MNMD Dividends
Mind Medicine Inc has its next earnings report out on 2024-Oct-31. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Mind Medicine Inc (NASDAQ:MNMD)’s Major holders
Mind Medicine Inc insiders hold 1.04% of total outstanding shares, with institutional holders owning 52.20% of the shares at 52.74% float percentage. In total, 52.20% institutions holds shares in the company, led by HUNTINGTON NATIONAL BANK. As of 2024-06-30, the company held over 1.0 shares.
